Reviews
GLP-1 provider reviews
Every provider we've put through the WeighScore rubric, with its grade and one-line read. Tap any provider for the full factor breakdown. Shopping a molecule? Start with the best semaglutide providers.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Showing 521–536 of 536 graded providers, 40 at a time — page 14 of 14.
- CRefills#525 · 51/100Refills (refills.com) is a LegitScript-certified online pharmacy and telehealth platform offering compounded GLP-1 weight-loss prescriptions (semaglutide, tirzepatide) alongside ED, hair growth, and daily wellness treatments.Visit
FDAWarning letter issued to Refills Health, LLC dba Refills Health in February 2026. See the FDA warning-letter database.
- CBlue Haven RX#526 · 50.8/100Blue Haven RX is a telehealth weight-loss program offering compounded GLP-1 on flat monthly pricing: semaglutide at $179/month and tirzepatide at $259/month, with the cost covering the doctor consultation, prescription, medication and free shipping (intro offers run as low as $149/month).Visit
- CAM Rx#528 · 49.9/100AM Rx (getamrx.com) is a telehealth platform operated by FitRX, LLC (also operates Zealthy and FitRx).Visit
FDAWarning letter issued to FitRX, LLC dba AM RX in June 2026. See the FDA warning-letter database.
- CBasal Health#532 · 47.7/100Basal Health is a national GLP-1 telehealth platform built around a metabolic-medicine framework, positioning GLP-1 therapy as one piece of a five-marker picture — insulin sensitivity, muscle mass, hormonal response, VO2 max, and body fat — with clinician-supervised, adaptive dosing rather than a fixed protocol.Visit
- CZealthy#533 · 46.7/100Zealthy (legal entity FitRX, LLC, recently renamed to Gronk Inc.) offers compounded semaglutide and tirzepatide via an asynchronous telehealth model.Visit
FDAWarning letter issued to FitRX, LLC dba Zealthy in September 2025. See the FDA warning-letter database.